Granite Investment Partners LLC purchased a new stake in shares of Castlight Health, inc. (NYSE:CSLT) during the second quarter, Holdings Channel reports. The fund purchased 388,680 shares of the software maker’s stock, valued at approximately $1,613,000.

Several other large investors have also recently made changes to their positions in CSLT. Schwab Charles Investment Management Inc. boosted its stake in shares of Castlight Health, inc. by 25.5% in the second quarter. Schwab Charles Investment Management Inc. now owns 249,281 shares of the software maker’s stock valued at $1,035,000 after buying an additional 50,687 shares during the last quarter. Edge Wealth Management LLC boosted its stake in shares of Castlight Health, inc. by 6.5% in the second quarter. Edge Wealth Management LLC now owns 50,050 shares of the software maker’s stock valued at $198,000 after buying an additional 3,050 shares during the last quarter. FNY Partners Fund LP purchased a new stake in shares of Castlight Health, inc. during the first quarter valued at approximately $164,000. Continental Advisors LLC boosted its stake in shares of Castlight Health, inc. by 36.4% in the first quarter. Continental Advisors LLC now owns 169,100 shares of the software maker’s stock valued at $617,000 after buying an additional 45,100 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its stake in shares of Castlight Health, inc. by 2.3% in the first quarter. Renaissance Technologies LLC now owns 922,800 shares of the software maker’s stock valued at $3,368,000 after buying an additional 20,610 shares during the last quarter. 39.10% of the stock is owned by institutional investors and hedge funds.

Shares of Castlight Health, inc. (NYSE CSLT) opened at 3.95 on Friday. Castlight Health, inc. has a 12-month low of $3.05 and a 12-month high of $5.50. The firm’s market capitalization is $520.16 million. The company has a 50-day moving average price of $4.27 and a 200 day moving average price of $3.79.

Castlight Health, inc. (NYSE:CSLT) last posted its quarterly earnings data on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.09) by $0.02. The business had revenue of $32.10 million during the quarter, compared to the consensus estimate of $31.14 million. Castlight Health, inc. had a negative return on equity of 36.30% and a negative net margin of 42.54%. Castlight Health, inc.’s quarterly revenue was up 36.0% on a year-over-year basis. During the same period last year, the company earned ($0.11) earnings per share. Equities research analysts expect that Castlight Health, inc. will post ($0.25) earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Granite Investment Partners LLC Invests $1.61 Million in Castlight Health, inc. (NYSE:CSLT)” was published by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://www.watchlistnews.com/granite-investment-partners-llc-invests-1-61-million-in-castlight-health-inc-nysecslt/1481247.html.

Several brokerages recently commented on CSLT. ValuEngine cut Castlight Health, inc. from a “hold” rating to a “sell” rating in a research note on Thursday. Cowen and Company reissued a “market perform” rating and issued a $4.50 price target (up previously from $4.00) on shares of Castlight Health, inc. in a research note on Thursday, August 3rd. BidaskClub cut Castlight Health, inc. from a “hold” rating to a “sell” rating in a research note on Sunday, July 30th. Zacks Investment Research raised Castlight Health, inc. from a “sell” rating to a “hold” rating in a research note on Tuesday, June 27th. Finally, Chardan Capital began coverage on Castlight Health, inc. in a research note on Tuesday, June 6th. They issued a “buy” rating and a $4.50 price target for the company. Three analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $4.57.

In other Castlight Health, inc. news, CAO Priya Jain sold 7,858 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $3.65, for a total value of $28,681.70. Following the completion of the transaction, the chief accounting officer now directly owns 20,000 shares in the company, valued at $73,000. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Giovanni M. Colella sold 11,456 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $3.75, for a total value of $42,960.00. Following the completion of the transaction, the insider now owns 88,094 shares of the company’s stock, valued at $330,352.50. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 60,051 shares of company stock valued at $233,723. 37.43% of the stock is owned by corporate insiders.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Want to see what other hedge funds are holding CSLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Castlight Health, inc. (NYSE:CSLT).

Institutional Ownership by Quarter for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.